Working draft · source control

Source Library

按证据强度分层：primary sources 用于核心事实和法律规则，secondary reports 只用于 settlement economics 或商业背景，internal analysis 用于技术事实和本案假设。

Primary sources

PatentEP3684786B1EP claim scope and 70% homolog language. PatentUS12091434B2U.S. claim scope and homolog structure. OpinionJuno v. KiteCAR-T high damages anchor, reversed on written description. OpinionAmgen v. SanofiFull-scope enablement for broad functional genus claims. OpinionBaxalta v. GenentechPost-Amgen biologics enablement application. Statute35 U.S.C. §284Reasonable royalty floor and enhanced damages. EUDirective 2004/48/ECEU enforcement and damages framework. UPCUPC Article 68UPC damages framework.

Damages methodology

MethodGeorgia-PacificReasonable royalty hypothetical negotiation factors. MethodPanduitLost profits test. MethodLucent v. GatewayComparable license and damages theory support. MethodLaserDynamicsApportionment and entire market value rule.

Secondary reports and commercial context

ReportJuno / Novartis settlementReported upfront, milestones, and royalty structure. ReportJones Day matter pageCounsel-side description of CAR patent settlement. CommercialKelonia / LillyCommercial incentive context for in vivo CAR-T delivery IP.

Internal analysis and local files

Local file	Role	Use level
`reference/0701-case-study/patent&conflict/突变位点专利分析.docx`	Local technical/patent summary: Cocal/VSV-G identity, China mainland layout, EP/US family status.	Internal technical fact base; counsel verification needed.
`reference/0701-case-study/case-files/`	Downloaded PDFs / HTML snapshots of key case and patent files.	Evidence folder for offline review.
`docs/case-dossiers.md`	Bilingual facts, files, analysis, and conclusions for each case.	Internal memo source; not external legal opinion.